MIRM - Mirum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

MIRM is currently covered by 14 analysts with an average price target of $144.28. This is a potential upside of $51.79 (56%) from yesterday's end of day stock price of $92.49.

Our record on Mirum Pharmaceuticals covers 21 analysts since 2008; 14 cover it today. Of the 220 price targets those analysts set on MIRM, 174 were reached (79%). The highest performance score on Mirum Pharmaceuticals belongs to Brian Skorney of Baird: 4.69, with 13 of 15 targets met in 216 days on average. The latest calls: Yigal Nochomovitz of Citi raised the target to $194 from $184 with a Buy rating on 11 Nov 2026; Lisa Walter of RBC kept the target at $155 with a Buy rating on 4 Nov 2026; Swayampakula Ramakanth of H.C. Wainwright raised the target to $202 from $200 with a Buy rating on 4 Nov 2026. Figures as of 18 Nov 2026.

Mirum Pharmaceuticals's activity chart (see below) currently has 250 price targets and 221 ratings on display. The stock rating distribution of MIRM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 73.58% of the time, taking 388.97 days on average.

Highest price target for MIRM is $202, Lowest price target is $110, average price target is $144.28.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 11-Nov-2026. First documented stock forecast 12-Aug-2019.

Best performing analysts who are covering MIRM - Mirum Pharmaceuticals:

Yasmeen Rahimi Steven Seedhouse Ed Arce Jonathan Wolleben Gavin Clark-Gartner Joseph Thome

Currently out of the existing stock ratings of MIRM, 58 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jun-2026

$194

$100.01 (106.40%)

$184

7 days ago
(11-Nov-2026)

0/4 (0%)

$99.58 (105.46%)

Buy Since 07-May-2026

$155

$61.01 (64.91%)

$155

14 days ago
(04-Nov-2026)

0/5 (0%)

$58.03 (59.84%)

Buy Since 19-May-2025

$202

$108.01 (114.92%)

$200

14 days ago
(04-Nov-2026)

4/12 (33.33%)

$105.03 (108.31%)

75

Buy Since 24-Oct-2023

$160

$66.01 (70.23%)

$140

14 days ago
(04-Nov-2026)

10/12 (83.33%)

$63.03 (65.00%)

243

Buy Since 20-Sep-2023

$167

$73.01 (77.68%)

$137

14 days ago
(04-Nov-2026)

15/26 (57.69%)

$70.03 (72.22%)

415

Show more analysts

Please expand the browser size to see the chart

What is MIRM (Mirum Pharmaceuticals) average time for price targets to be met?

On average it took 389 days for the stock forecasts to be reached, with an average price target met ratio of 73.58%.

Which analyst most recently updated their price target on MIRM (Mirum Pharmaceuticals)?

Yigal Nochomovitz

Which analyst has the most public recommendations on MIRM (Mirum Pharmaceuticals)?

Yigal Nochomovitz works at CITI and has 13 price targets and 9 ratings on MIRM

Which analyst is the currently most bullish on MIRM (Mirum Pharmaceuticals)?

Swayampakula Ramakanth with the highest potential upside of $108.01

Which analyst is the currently most reserved on MIRM (Mirum Pharmaceuticals)?

Joe Ritchie with the lowest potential downside of -$83.2
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?